ArticleVaccines2026

An Expert Perspective on a New Recombinant Pertussis-Only Vaccine and Its Potential Clinical and Programmatic Advantages in Australia, New Zealand, and Beyond.

Peter McIntyre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.